Thromb Haemost 1986; 56(03): 256-259
DOI: 10.1055/s-0038-1661661
Original Article
Schattauer GmbH Stuttgart

Interleukin 1 Stimulates Endothelial Cell Tissue Factor Production and Expression by a Prostaglandin-Independent Mechanism

Anna E Schorer
The Minneapolis Veterans Administration Medical Center and the University of Minnesota Medical Center, Minneapolis, Minnesota, USA
,
Manuel E Kaplan
The Minneapolis Veterans Administration Medical Center and the University of Minnesota Medical Center, Minneapolis, Minnesota, USA
,
Gundu H R Rao
The Minneapolis Veterans Administration Medical Center and the University of Minnesota Medical Center, Minneapolis, Minnesota, USA
,
Charles F Moldow
The Minneapolis Veterans Administration Medical Center and the University of Minnesota Medical Center, Minneapolis, Minnesota, USA
› Author Affiliations
Further Information

Publication History

Received 11 March 1986

Accepted after revision 19 August 1986

Publication Date:
18 July 2018 (online)

Summary

Activation of coagulation occurs at inflammatory sites following the ingress of mononuclear cells, and may result from alterations in the vessel wall. Since the monokine, interleukin 1, initiates diverse responses to inflammation, its ability to enhance vascular procoagulant activity was studied. Interleukin 1-treated cultured human endothelial cells acquired elevated levels of the procoagulant, tissue factor. This required de novo protein synthesis, was maximal at 2 h after exposure to interleukin 1, and resulted in persistently elevated cellular procoagulant activity. Tissue factor was later expressed (6-24 h) on the surface of uninjured endothelial cells. Endothelial cell procoagulant production and expression in response to interleukin 1 could be dissociated from endogenous prostaglandin metabolism, being insensitive to hydrocortisone, indomethacin, eicosatetrayionic acid and exogenous arachidonic acid. In addition, no increase in prostaglandin synthesis occurred during the interval in which tissue factor was synthesized. We therefore conclude that interleukin 1 stimulates endothelial synthesis and surface expression of tissue factor by a prostaglandin-independent mechanism.

 
  • References

  • 1 Colvin RB, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity I. Fibrin deposition in delayed skin reactions in man. J Exp Med 1973; 138: 686-698
  • 2 Zimmerman TS, Fierer J, Rothberger H. Blood coagulation and the inflammatory response. Semin Hematol 1977; 14: 391-408
  • 3 Stern D, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Nat Acad Sci USA 1985; 82: 2523-2527
  • 4 Busch C, Owen WG. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. J Clin Invest 1982; 69: 726-729
  • 5 Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982; 94: 631-636
  • 6 Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semieraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
  • 7 Lyberg T, Gaidai KS, Evensen SA, Prydz H. Cellular cooperation in endothelial thromboplastin synthesis. Br J Haematol 1983; 53: 85-95
  • 8 Montesano R, Orci L, Vassalli P. Human endothelial cultures: Phenotypic modulation by leukocyte interleukins. J Cell Physiol 1985; 122: 424-424
  • 9 Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone Jr MA. Interleukin 1 (IL1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-623
  • 10 Eldor A, Fridman R, Vlodavsky I, Hy-Am E, Fuks Z, Panet A. Interferon enhances prostacyclin production by cultured vascular endothelial cells. J Clin Invest 1984; 73: 251-257
  • 11 Dinarello CA. Interleukin 1. Rev Infect Dis 1984; 6: 51-95
  • 12 Beller DI, Farr AG, Unanue ER. The regulation of lymphocyte proliferation and differentiation by macrophages. Fed Proc Fed Am Soc Exp Biol 1978; 37: 91-96
  • 13 Root RK, Wolff SM. Pathogenetic mechanisms in experimental immune fever. J Exp Med 1968; 128: 309-323
  • 14 Loceani F, Bishai I, Dinarello CA, Fitzpatrick FA. Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cats. Am J Physiol 1983; 244: 785-793
  • 15 Kampschmidt RF, Upchurch HF. Effect of leukocytic endogenous mediator on plasma fibrinogen and haptoglobin. Proc Soc Exp Biol Med 1974; 146: 904-907
  • 16 Mizel SB, Dayer J-M, Krane SM, Mergenhagen SE. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Nat Acad Sci USA 1981; 78: 2474-2477
  • 17 Rossi V, Breviario F, Ghezzi P, Dejana E, Mantovani A. Prostacyclin synthesis induced in vascular cells by Interleukin-1. Science 1985; 229: 174-176
  • 18 Callahan KS. Personal communication
  • 19 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins; identification of morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
  • 20 Schorer AE, Rick PD, Swaim WR, Moldow CF. Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial injury. J Lab Clin Med 1985; 106: 38-42
  • 21 Moldow CF, Jacob HS. Endothelial culture, neutrophil or enzymic generation of free radicals: In Vitro methods for the study of endothelial injury. In: Methods in Enzymology Lester Packer. Ed Academic Press; New York: 1984. 105 378-385
  • 22 Mizel SB. Studies on the purification and structure-function relationships of murine lymphocyte activating factor (interleukin 1). Mol Immunol 1980; 17: 571-577
  • 23 Nawroth PP, Stern DM, Kisiel W, Bach R. Cellular requirements for tissue factor generation by bovine endothelial cells in culture. Thromb Res 1985; 40: 677-681
  • 24 Tanaka T, Ohmura T, Yamakado T, Hidaka H. Two types of calcium-dependent protein phophorylations modulated by calmodulin antagonists; naphthalenesul-fonamide derivatives. Mol Pharmacol 1982; 22: 408-412
  • 25 Parant M, Riveau G, Parant F, Dinarello CA, Wolff SM, Chedid L. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dopeptide. J Infect Dis 1980; 142: 708-715
  • 26 Crutchley DJ. Effects of Inhibitors of Arachidonic Acid Metabolism on Thromboplastin Activity in Human Monocytes. Biochem Biochem Res Commun 1984; 119: 179-184
  • 27 Zeldis SM, Nemerson Y, Pitlick FA. Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science 1971; 175: 766-768
  • 28 Stern DM, Bank I, Nawroth PP, Cassimeris J, Kisiel W, Fenton JW II, Dinarello C, Chess L, Jaffe EA. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985; 162: 1223-1235
  • 29 Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 1986; 136: 649-654
  • 30 Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone Jr MA. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 1985; 76: 2003-2011